NCT06669247
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06669247
Title A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma (COSTIMM)
Acronym COSTIMM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR | AUS

Facility Status City State Zip Country Details
Illawarra Cancer Care Centre RECRUITING Wollongong New South Wales 2500 Australia Details
Pindara Private Hospital RECRUITING Benowa Queensland 4217 Australia Details
Royal Adelaide Hospital RECRUITING Adelaide South Australia 5000 Australia Details
St Vincent's Hospital - Melbourne RECRUITING Fitzroy Victoria 3065 Australia Details
Alfred Hospital RECRUITING Melbourne Victoria 3004 Australia Details
University College London Hospitals RECRUITING London NW1 2PG United Kingdom Details
The Christie NHS Foundation Trust RECRUITING Manchester M20 4BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field